Collectively, these data highlight the importance of integrating metabolic health into early therapeutic strategies for PsA, particularly in individuals at high risk of disease progression or in those presenting with subclinical musculoskeletal involvement
Itll change your life, just like it did mine! Thomas Fitzpatrick, Toronto, Canada Ive struggled with insecurity and discomfort due to swollen lymph nodes on my neck for as long as I can remember, and its caused me a lot of distress in life
Nature Medicine, 21(1), 27-36
The question of weight regain following retatrutide discontinuation is not yet answered in published data
This section will briefly review what we know about the current safety data of GLP-1 and GLP-1/GIP agonists, and factors that may promote long term clinical use of these agents in obesity
Some studies are looking at the possibility these medications could negatively impact our natural GLP-1 pathway